| Phase 1/2 |
| NCT07549698 |
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory… |
Warm Autoimmune Hemolytic Anemia (WAIHA) |
Recruiting |
2026-09-22 |
| NCT07758634 |
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With… |
Hypertension |
Recruiting |
2026-08-11 |
| NCT05643742 |
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory… |
B-cell Lymphoma |
Recruiting |
2025-11-14 |
| NCT07850076 |
A Trial Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and… |
Alpha-1 Antitrypsin Deficiency (AATD) |
Not Yet Recruiting |
2026-09-30 |
| NCT07804004 |
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic… |
Progressive Multiple Sclerosis (PMS) |
Not Yet Recruiting |
2026-09-09 |
| Phase 1 |
| NCT07491172 |
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory… |
Cardiovascular |
Recruiting |
2026-09-18 |
| NCT06925542 |
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory… |
SLE (Systemic Lupus) |
Recruiting |
2026-08-28 |
| Not specified |
| NCT06208878 |
A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies |
Hematologic Malignancy |
Enrolling by Invitation |
2026-09-24 |